These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38678552)
1. Anti-NSCLC role of SCN4B by negative regulation of the cGMP-PKG pathway: Integrated utilization of bioinformatics analysis and in vitro assay validation. Yang X; Liu Q; Li G Drug Dev Res; 2024 May; 85(3):e22192. PubMed ID: 38678552 [TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells. Wong JC; Bathina M; Fiscus RR J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515 [TBL] [Abstract][Full Text] [Related]
3. STEAP4 knockdown inhibits the proliferation of prostate cancer cells by activating the cGMP-PKG pathway under lipopolysaccharide-induced inflammatory microenvironment. Li W; Yin X; Yan Y; Liu C; Li G Int Immunopharmacol; 2021 Dec; 101(Pt B):108311. PubMed ID: 34768126 [TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR. He RQ; Cen WL; Cen JM; Cen WN; Li JY; Li MW; Gan TQ; Hu XH; Chen G Cell Physiol Biochem; 2018; 46(3):925-952. PubMed ID: 29669324 [TBL] [Abstract][Full Text] [Related]
5. Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study. Yin Z; Zhang X; Sun X; Huo Y; Ji N; Chen K Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1753-C1768. PubMed ID: 38682239 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development. Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325 [TBL] [Abstract][Full Text] [Related]
7. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses. Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858 [TBL] [Abstract][Full Text] [Related]
10. Identification of Key Genes and Signaling Pathways in Entrectinibresistant Non-small Cell Lung Cancer Using Bioinformatic Analysis and Experimental Verification. Chen X; Zhao X; Li D; Zha W Curr Med Chem; 2024 Aug; ():. PubMed ID: 39108112 [TBL] [Abstract][Full Text] [Related]
11. GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation. Zhao M; Li X; Chen X J Bioenerg Biomembr; 2021 Apr; 53(2):177-189. PubMed ID: 33538941 [TBL] [Abstract][Full Text] [Related]
12. Dysregulated Sui J; Zhao Q; Zhang Y; Liang G DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469 [TBL] [Abstract][Full Text] [Related]
13. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression. Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of key genes associated with non-small-cell lung cancer. Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628 [TBL] [Abstract][Full Text] [Related]
15. RBBP4: A novel diagnostic and prognostic biomarker for non-small-cell lung cancer correlated with autophagic cell death. Zhan Y; Zhang Z; Yin A; Su X; Tang N; Chen Y; Zhang Z; Chen W; Wang J; Wang W Cancer Med; 2024 Aug; 13(15):e70090. PubMed ID: 39109577 [TBL] [Abstract][Full Text] [Related]
16. Paeonol upregulates expression of tumor suppressors TNNC1 and SCARA5, exerting anti-tumor activity in non-small cell lung cancer cells. Zhang C; Zhang J; Guo K Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5241-5251. PubMed ID: 38265681 [TBL] [Abstract][Full Text] [Related]
17. mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9. Liu B; Wang R; Liu H Biomed Res Int; 2021; 2021():6622342. PubMed ID: 34055989 [TBL] [Abstract][Full Text] [Related]
18. Krüppel-Like Factor 6 Downregulation Is Connected with a Poor Prognosis and Tumor Growth in Non-Small-Cell Lung Cancer. Zeng B; Lin J; Cai X; Che L; Zeng W; Liu S Comput Math Methods Med; 2022; 2022():3193553. PubMed ID: 35136416 [TBL] [Abstract][Full Text] [Related]
19. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis. Wu X; Li X; Xu G Oncol Rep; 2020 Aug; 44(2):487-498. PubMed ID: 32468043 [TBL] [Abstract][Full Text] [Related]
20. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]